Clinical trials of endothelin antagonists in heart failure: publication is good for the public health.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 17170334.
- Also identified by PMC identifier 1861328.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The failure of endothelin antagonists to show benefit in heart failure cannot be understood until all the clinical trials are fully published.
Medical subject headings
- Antihypertensive Agents
- Clinical Trials as Topic
- Endothelin A Receptor Antagonists
- Heart Failure